137 related articles for article (PubMed ID: 3243217)
21. [Effects of extracorporeal hemo-correction on lipid peroxidation in patients in critical states].
Chalenko VV; Zhilkina SV; Pastukhova NK; Kutushev FKh; Romanchishen AF
Vestn Khir Im I I Grek; 2001; 160(3):55-9. PubMed ID: 11517792
[TBL] [Abstract][Full Text] [Related]
22. [Management of resistant hypertension].
Briet M; Bobrie G; Azizi M
Rev Prat; 2013 May; 63(5):681-8. PubMed ID: 23789498
[TBL] [Abstract][Full Text] [Related]
23. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
Hagino T; Abe K; Tsunoda K; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765
[TBL] [Abstract][Full Text] [Related]
24. [Levels of biologically active substances in the blood of patients resistant and nonresistant to antihypertensive therapy].
Tabak'ian EA; Dmitriev VV; Masenko VP; Kukharchuk VV
Ter Arkh; 1999; 71(3):62-7. PubMed ID: 10234770
[TBL] [Abstract][Full Text] [Related]
25. [The evaluation of the efficacy of hemosorption and plasmapheresis in IHD complicated by chronic heart failure].
Koriakova NN; Rozhdestvenskaia ED; Zlokazov VB
Ter Arkh; 1996; 68(5):71-3. PubMed ID: 9082607
[TBL] [Abstract][Full Text] [Related]
26. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
27. [Effects of plasmapheresis on lymphocytic energy enzymes in hypertension].
Kuznetsov SV; Kim IS; Ananchenko VG
Sov Med; 1990; (5):25-8. PubMed ID: 2389196
[TBL] [Abstract][Full Text] [Related]
28. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
Danilov NM; Matchin IuG; Chazova IE
Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
[TBL] [Abstract][Full Text] [Related]
29. [The effects of plasmapheresis on central hemodynamics and cerebral circulation in hypertensive patients].
Alizade IG; Karaeva NT
Klin Med (Mosk); 1996; 74(5):32-3. PubMed ID: 8999179
[TBL] [Abstract][Full Text] [Related]
30. [Use of hemosorption and plasmapheresis in the treatment of patients with rheumatoid arthritis, bronchial asthma and hypertension].
Ananchenko VG; Strizhova NV; Kuznetsov SV; Griaznova NA; Alizade IG
Klin Med (Mosk); 1991 Aug; 69(8):87-9. PubMed ID: 1838781
[No Abstract] [Full Text] [Related]
31. [Hypertensive emergency with clinical signs of a thrombotic microangiopathy].
Schauseil A; Rump LC; Quack I
Dtsch Med Wochenschr; 2012 Nov; 137(48):2476-9. PubMed ID: 23168979
[TBL] [Abstract][Full Text] [Related]
32. [Extracorporeal therapy (hemosorption, plasmapheresis) in the combined treatment of severe forms of Sjögren's disease].
Chiklikchi AS; Vasil'ev VI; Simonova MV; Mach ES
Vutr Boles; 1988; 27(6):58-62. PubMed ID: 3247707
[TBL] [Abstract][Full Text] [Related]
33. [Malignant arterial hypertension disclosing late congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency].
Ribstein J; Sciolla JP; Barjon P; Sultan C; Forest M; de Peretti E
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():93-5. PubMed ID: 3142437
[TBL] [Abstract][Full Text] [Related]
34. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the effectiveness of plasmapheresis in the treatment of patients with severe arterial hypertension].
Kukharchuk VV; Legkonogov AV; Kutsenko AI; Arabidze GG; Zaruba AIu
Klin Med (Mosk); 1987 Oct; 65(10):20-5. PubMed ID: 3431050
[No Abstract] [Full Text] [Related]
36. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
37. [Optimization of the treatment of patients with hypertensive disease from the rheological viewpoint].
Shabanov VA; Kitaeva ND; Levin GIa; Karsakov VV; Kostrov VA
Kardiologiia; 1991 Feb; 31(2):67-70. PubMed ID: 2041297
[TBL] [Abstract][Full Text] [Related]
38. [Hypotensive effect of plasmapheresis in severe arterial hypertension].
Mikhaĭlov AA; Vorob'ev PA; Dvoretskiĭ LI; Zaĭtsev SV; Iaroslavtseva GN
Kardiologiia; 1986 Oct; 26(10):98-9. PubMed ID: 3795714
[No Abstract] [Full Text] [Related]
39. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
[TBL] [Abstract][Full Text] [Related]
40. The role of arterial hypertension in the progression of non-diabetic glomerular diseases.
Ljutić D; Kes P
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v28-30. PubMed ID: 12817064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
